[Severe human parechovirus-3 sepsis in a 6-week-old infant]

Arch Pediatr. 2014 Apr;21(4):399-401. doi: 10.1016/j.arcped.2014.01.011. Epub 2014 Mar 11.
[Article in French]

Abstract

Febrile infants under 3 months of age are often treated with broad-spectrum intravenous antibiotics while awaiting culture results, to prevent mother-to-child bacterial infections. Human parechoviruses (HPeV) have recently been described as etiologic agents of meningitis and severe sepsis in neonates and young infants. They are rarely investigated and are therefore probably underestimated. They cause acute clinical symptoms that can incorrectly suggest a bacterial infection. In the present case, a 6-week-old infant infected with HPeV developed severe sepsis, complicated by hepatic cytolysis, meningitis, acute renal failure, and mild hemophagocytic lymphohistiocytosis. HPeV type 3 was found by routine specific RT-PCR in cerebrospinal fluid, stools, and plasma. The outcome was spontaneously favorable after 4 days. Early diagnosis of the HPeV infection by routine specific RT-PCR reduces unnecessary antibiotic use and extended hospitalization in febrile young infants.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / virology
  • Anti-Bacterial Agents / therapeutic use
  • Cefotaxime / therapeutic use
  • Citrobacter freundii / isolation & purification
  • Drug Therapy, Combination
  • Early Diagnosis
  • Enterobacteriaceae Infections / complications
  • Gentamicins / therapeutic use
  • Humans
  • Infant
  • Male
  • Meningitis, Viral / diagnosis*
  • Meningitis, Viral / drug therapy
  • Meningitis, Viral / virology
  • Parechovirus / isolation & purification*
  • Picornaviridae Infections / complications
  • Picornaviridae Infections / diagnosis*
  • Picornaviridae Infections / drug therapy
  • Picornaviridae Infections / virology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Risk Factors
  • Severity of Illness Index
  • Treatment Outcome
  • Viremia / diagnosis*
  • Viremia / virology

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Cefotaxime